Liu L - Search Results

1

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.

Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S. Xu Y, et al. Among authors: liu l, liu s. J Oncol. 2022 Apr 20;2022:1525245. doi: 10.1155/2022/1525245. eCollection 2022. J Oncol. 2022. PMID: 35498539 Free PMC article.

2

Liu L, Chen C, Tu G, Peng Y, Shen M, Xu Y, Liu S. Liu L, et al. Among authors: liu s. Front Cell Dev Biol. 2022 Mar 4;10:821727. doi: 10.3389/fcell.2022.821727. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35309942 Free PMC article.

3

Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer.

Chen R, Guo S, Yang C, Sun L, Zong B, Li K, Liu L, Tu G, Liu M, Liu S. Chen R, et al. Among authors: liu m, liu l, liu s. Int J Oncol. 2020 Apr;56(4):932-944. doi: 10.3892/ijo.2020.4987. Epub 2020 Feb 14. Int J Oncol. 2020. PMID: 32319562 Free PMC article.

4

Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer.

Liu L, Chen W, Li Y, Fu P, Cao Y, Li Z, Xiong J, Jie Z. Liu L, et al. J Oncol. 2022 Jan 18;2022:2035808. doi: 10.1155/2022/2035808. eCollection 2022. J Oncol. 2022. PMID: 35087586 Free PMC article.

5

GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells.

Liu L, Liu S, Luo H, Chen C, Zhang X, He L, Tu G. Liu L, et al. Among authors: liu s. Aging (Albany NY). 2021 Jun 28;13(12):16178-16197. doi: 10.18632/aging.203145. Epub 2021 Jun 28. Aging (Albany NY). 2021. PMID: 34182538 Free PMC article.

6

Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.

Yan P, Tang L, Liu L, Tu G. Yan P, et al. Among authors: liu l. Oncol Lett. 2020 Mar;19(3):1915-1927. doi: 10.3892/ol.2020.11292. Epub 2020 Jan 10. Oncol Lett. 2020. PMID: 32194687 Free PMC article.

7

Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World Study.

Qu J, Kalyani FS, Shen Q, Yang G, Cheng T, Liu L, Zhou J, Zhou J. Qu J, et al. Among authors: liu l. J Oncol. 2022 Sep 26;2022:3645489. doi: 10.1155/2022/3645489. eCollection 2022. J Oncol. 2022. PMID: 36199793 Free PMC article.

8

Downregulated expression of IL‑28RA is involved in the pathogenesis of pancreatic ductal adenocarcinoma.

Liu L, Qi Y, Huang D, Xu Y, Li M, Hong Z, Gu Y, Jia B, Luo X, Zhang S, Zhang S. Liu L, et al. Int J Oncol. 2021 Aug;59(2):55. doi: 10.3892/ijo.2021.5235. Epub 2021 Jul 1. Int J Oncol. 2021. PMID: 34195850

9

HLTF suppresses the migration and invasion of colorectal cancer cells via TGF‑β/SMAD signaling in vitro.

Liu L, Liu H, Zhou Y, He J, Liu Q, Wang J, Zeng M, Yuan D, Tan F, Zhou Y, Pei H, Zhu H. Liu L, et al. Among authors: liu h, liu q. Int J Oncol. 2018 Dec;53(6):2780-2788. doi: 10.3892/ijo.2018.4591. Epub 2018 Oct 10. Int J Oncol. 2018. PMID: 30320371

10

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.

Li J, Zhao L, Pan Y, Ma X, Liu L, Wang W, You W. Li J, et al. Among authors: liu l. Int J Oncol. 2020 Sep;57(3):756-766. doi: 10.3892/ijo.2020.5095. Epub 2020 Jul 7. Int J Oncol. 2020. PMID: 32705243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,574 results

Search Page

Filters